China Medical System Holdings (HKSE:00867) EBIT per Share : HK$1.30 (TTM As of Dec. 2023)

View and export this data going back to 2010. Start your Free Trial

What is China Medical System Holdings EBIT per Share?

China Medical System Holdings's EBIT per Share for the six months ended in Dec. 2023 was HK$0.28. Its EBIT per Share for the trailing twelve months (TTM) ended in Dec. 2023 was HK$1.30.

During the past 12 months, the average EBIT per Share Growth Rate of China Medical System Holdings was -23.90% per year. During the past 3 years, the average EBIT per Share Growth Rate was -2.10% per year. During the past 5 years, the average EBIT per Share Growth Rate was 9.10% per year. During the past 10 years, the average EBIT per Share Growth Rate was 16.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.

The historical rank and industry rank for China Medical System Holdings's EBIT per Share or its related term are showing as below:

HKSE:00867' s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -48.5 Med: 20.2 Max: 36
Current: -2.1

During the past 13 years, the highest 3-Year average EBIT per Share Growth Rate of China Medical System Holdings was 36.00% per year. The lowest was -48.50% per year. And the median was 20.20% per year.

HKSE:00867's 3-Year EBIT Growth Rate is ranked worse than
65.89% of 862 companies
in the Drug Manufacturers industry
Industry Median: 7.25 vs HKSE:00867: -2.10

China Medical System Holdings's EBIT for the six months ended in Dec. 2023 was HK$674 Mil.

China Medical System Holdings EBIT per Share Historical Data

The historical data trend for China Medical System Holdings's EBIT per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

China Medical System Holdings EBIT per Share Chart

China Medical System Holdings Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

EBIT per Share

Get a 7-Day Free Trial

1.14

1.36

1.73

1.74

1.30

China Medical System Holdings Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
EBIT per Share	Get a 7-Day Free Trial															0.83	0.99	0.79	1.03	0.28

China Medical System Holdings EBIT per Share Calculation

EBIT per Share is the amount of Earnings Before Interest and Taxes (EBIT) per outstanding share of the company's stock.

Earnings Before Interest and Taxes (EBIT) is what the company earns before it expenses interest and taxes.

China Medical System Holdings's EBIT per Share for the fiscal year that ended in Dec. 2023 is calculated as

	EBIT per Share		(A: Dec. 2023 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	3193.858	/	2451.989
=	1.30

China Medical System Holdings's EBIT per Share for the quarter that ended in Dec. 2023 is calculated as

	EBIT per Share		(Q: Dec. 2023 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	674.011	/	2451.989
=	0.27

EBIT per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$1.30

China Medical System Holdings (HKSE:00867) EBIT per Share Explanation

EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.

China Medical System Holdings EBIT per Share Related Terms

Thank you for viewing the detailed overview of China Medical System Holdings's EBIT per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

China Medical System Holdings (HKSE:00867) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » China Medical System Holdings Ltd (HKSE:00867) » Definitions » EBIT per Share

Comparable Companies

Traded in Other Exchanges

2M7C:Germany

Address

510 King’s Road, Unit 2106, 21st Floor, North Point, Island Place Tower, Hong Kong, HKG

Website

http://www.cms.net.cn

China Medical System Holdings Ltd is active in the healthcare segment. It is one of the leading China-based pharmaceutical services companies in the country. The company's business mainly involves the marketing, promotion, and sales of prescription pharmaceutical products manufactured by domestic pharmaceutical companies. Some of its products include Plendil; Salofalk; Combizym; Ganfule Capsules; Xidakang; Hirudoid; and others. Geographically, it derives revenue from China.

Executives

Treasure Sea Limited	2101 Beneficial owner
Lam Kong	2201 Interest of corporation controlled by you

China Medical System Holdings (HKSE:00867) Headlines

No Headlines